NEUROCRINE BIOSCIENCES INC - NBIX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$14.9B

QoQ value delta ($000)

+$731.9M (+5.17%)

Implied price effect (QoQ)

-6.42%

Total shares

112,347,706

QoQ shares delta

+12,376,498 (+12.38%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 692 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	1,763,419	13,385,607	0.03%
VANGUARD GROUP INC	1,375,793	9,700,301	0.02%
JPMORGAN CHASE & CO	721,355	5,604,067	0.05%
DODGE & COX	719,437	5,461,037	0.4%
AQR CAPITAL MANAGEMENT LLC	650,659	4,938,967	0.3%
VANGUARD PORTFOLIO MANAGEMENT LLC	622,648	4,726,344	0.03%
VANGUARD CAPITAL MANAGEMENT LLC	594,398	4,511,904	0.01%
STATE STREET CORP	573,665	4,354,526	0.02%
TWO SIGMA INVESTMENTS, LP	403,199	3,060,570	0.33%
RENAISSANCE TECHNOLOGIES LLC	318,665	2,418,897	0.5%
GEODE CAPITAL MANAGEMENT, LLC	280,802	2,136,672	0.02%
BNP Paribas Asset Management Holding S.A.	196,773	1,493,813	0.23%
WELLINGTON MANAGEMENT GROUP LLP	183,057	1,389,539	0.03%
Vestal Point Capital, LP	164,675	1,250,000	4.6%
MILLENNIUM MANAGEMENT LLC	164,338	1,247,447	0.07%
NORTHERN TRUST CORP	163,730	1,242,830	0.02%
NORGES BANK	162,664	1,146,896	0.02%
UBS Group AG	160,859	1,221,036	0.02%
MORGAN STANLEY	160,617	1,219,196	0.01%
RTW INVESTMENTS, LP	139,917	1,062,072	1.39%
FIRST TRUST ADVISORS LP	126,367	959,217	0.09%
TWO SIGMA ADVISERS, LP	119,504	842,592	0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	118,933	902,788	0.02%
IEQ CAPITAL, LLC	100,910	765,982	0.47%
VICTORY CAPITAL MANAGEMENT INC	96,382	731,609	0.06%